Cite
1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase.
MLA
Lai, Mei-Jung, et al. “1-Arylsulfonyl Indoline-Benzamides as a New Antitubulin Agents, with Inhibition of Histone Deacetylase.” European Journal of Medicinal Chemistry, vol. 162, Jan. 2019, pp. 612–30. EBSCOhost, https://doi.org/10.1016/j.ejmech.2018.10.066.
APA
Lai, M.-J., Ojha, R., Lin, M.-H., Liu, Y.-M., Lee, H.-Y., Lin, T. E., Hsu, K.-C., Chang, C.-Y., Chen, M.-C., Nepali, K., Chang, J.-Y., & Liou, J.-P. (2019). 1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase. European Journal of Medicinal Chemistry, 162, 612–630. https://doi.org/10.1016/j.ejmech.2018.10.066
Chicago
Lai, Mei-Jung, Ritu Ojha, Mei-Hsiang Lin, Yi-Min Liu, Hsueh-Yun Lee, Tony Eight Lin, Kai-Cheng Hsu, et al. 2019. “1-Arylsulfonyl Indoline-Benzamides as a New Antitubulin Agents, with Inhibition of Histone Deacetylase.” European Journal of Medicinal Chemistry 162 (January): 612–30. doi:10.1016/j.ejmech.2018.10.066.